RankingsPricing
  1. JP-listed companies
  2. OncoTherapy Science, Inc.
  3. Financials
  4. Net income

OncoTherapy Science, Inc.【JP:4564】

Market cap
¥6.7B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 2025-815-36.71%
Mar 31, 2024-1,288+15.15%
Mar 31, 2023-1,119-56.50%
Mar 31, 2022-2,572+64.67%
Mar 31, 2021-1,562-30.24%
Mar 31, 2020-2,239-23.73%
Mar 31, 2019-2,935+2.94%
Mar 31, 2018-2,851-5.03%
Mar 31, 2017-3,002+7.65%
Mar 31, 2016-2,789+111.57%
Mar 31, 2015-1,318-65.50%
Mar 31, 2014-3,821+263.83%
Mar 31, 2013-1,050-240.94%
Mar 31, 2012745

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)